Marble Harbor Investment Counsel LLC Has $5.68 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Marble Harbor Investment Counsel LLC lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 12.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 608,872 shares of the pharmacy operator’s stock after selling 87,706 shares during the quarter. Marble Harbor Investment Counsel LLC owned 0.07% of Walgreens Boots Alliance worth $5,681,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Stephens Inc. AR increased its stake in Walgreens Boots Alliance by 94.0% in the 3rd quarter. Stephens Inc. AR now owns 30,090 shares of the pharmacy operator’s stock valued at $270,000 after buying an additional 14,581 shares during the period. Farther Finance Advisors LLC increased its position in Walgreens Boots Alliance by 56.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 5,831 shares of the pharmacy operator’s stock worth $52,000 after purchasing an additional 2,094 shares during the last quarter. Van ECK Associates Corp increased its position in Walgreens Boots Alliance by 21.3% in the 3rd quarter. Van ECK Associates Corp now owns 322,984 shares of the pharmacy operator’s stock worth $3,019,000 after purchasing an additional 56,725 shares during the last quarter. Asset Management One Co. Ltd. grew its stake in shares of Walgreens Boots Alliance by 9.2% in the 3rd quarter. Asset Management One Co. Ltd. now owns 393,500 shares of the pharmacy operator’s stock valued at $3,526,000 after buying an additional 33,253 shares in the last quarter. Finally, QRG Capital Management Inc. grew its stake in shares of Walgreens Boots Alliance by 85.9% in the 3rd quarter. QRG Capital Management Inc. now owns 31,706 shares of the pharmacy operator’s stock valued at $284,000 after buying an additional 14,651 shares in the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

WBA has been the subject of several recent research reports. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Bank of America upped their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Evercore ISI upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Finally, Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and an average target price of $11.54.

Walgreens Boots Alliance Stock Up 7.5 %

WBA opened at $11.39 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $22.05. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $9.84 billion, a price-to-earnings ratio of -1.11, a P/E/G ratio of 1.31 and a beta of 0.62. The business has a 50 day moving average of $10.64 and a 200-day moving average of $9.73.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period last year, the business posted $0.66 EPS. As a group, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.